Clinical trial
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With…
NCT00316836 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00316836 |
|---|---|
| Title | Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole |
| Official title | The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27 |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | mammography |
| Enrollment | 554 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Feb 1, 2012 |
| First posted | Apr 21, 2006 |
| Last update posted | Jan 24, 2019 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: